Role/NN
for/IN
the/DT
Epstein-Barr/JJ
virus/NN
nuclear/JJ
antigen/NN
2/CD
in/IN
viral/JJ
promoter/NN
switching/VBG
during/IN
initial/JJ
stages/NNS
of/IN
infection/NN
./.

During/IN
latent/JJ
Epstein-Barr/JJ
virus/NN
(/(
EBV/NN
)/)
infection/NN
of/IN
human/JJ
B/NN
lymphocytes/NNS
,/,
six/CD
viral/JJ
nuclear/JJ
antigen/NN
(/(
EBNAs/NNS
)/)
are/VBP
expressed/VBN
from/IN
long/JJ
primary/JJ
transcripts/NNS
by/IN
means/NNS
of/IN
alternative/JJ
splicing/NN
and/CC
alternative/JJ
polyadenylylation/NN
sites/NNS
./.
=====
These/DT
transcripts/NNS
initiate/VBP
from/IN
one/CD
of/IN
two/CD
promoters/NNS
,/,
Cp/NN
or/CC
Wp/NN
,/,
that/WDT
function/VBP
in/IN
a/DT
mutually/RB
exclusive/JJ
fashion/NN
./.
=====
Wp/NN
is/VBZ
exclusively/RB
utilized/VBN
during/IN
the/DT
initial/JJ
stages/NNS
of/IN
infection/NN
of/IN
primary/JJ
B/NN
lymphocytes/NNS
,/,
followed/VBN
by/IN
a/DT
switch/NN
to/TO
Cp/NN
usage/NN
./.
=====
These/DT
studies/NNS
have/VBP
been/VBN
extended/VBN
to/TO
show/VB
that/IN
(/(
i/LS
)/)
a/DT
mutant/JJ
EBV/NN
strain/NN
lacking/VBG
the/DT
gene/NN
encoding/VBG
EBNA/NN
2/CD
fails/VBZ
to/TO
switch/VB
from/IN
Wp/NN
to/TO
Cp/NN
usage/NN
in/IN
primary/JJ
B/NN
lymphocytes/NNS
,/,
although/IN
the/DT
virus/NN
contains/VBZ
a/DT
functional/JJ
Cp/NN
;/:
(/(
ii/LS
)/)
a/DT
region/NN
from/IN
-429/CD
to/TO
-245/CD
base/NN
pairs/NNS
upstream/JJ
of/IN
Cp/NN
is/VBZ
essential/JJ
for/IN
Cp/NN
activity/NN
in/IN
B/NN
lymphocytes/NNS
,/,
but/CC
only/RB
in/IN
the/DT
context/NN
of/IN
upstream/JJ
and/CC
downstream/JJ
sequences/NNS
;/:
(/(
iii/LS
)/)
this/DT
region/NN
contains/VBZ
an/DT
EBNA/NN
2-dependent/JJ
enhancer/NN
;/:
and/CC
(/(
iv/LS
)/)
DNase/NN
I/CD
protection/NN
employing/VBG
nuclear/JJ
extracts/NNS
from/IN
B/NN
and/CC
T/NN
lymphocytes/NNS
revealed/VBD
a/DT
B-cell-specific/JJ
footprint/NN
in/IN
the/DT
region/NN
of/IN
the/DT
EBNA/NN
2-dependent/JJ
enhancer/NN
./.
=====
These/DT
results/NNS
support/VBP
a/DT
model/NN
for/IN
viral/JJ
promoter/NN
switching/NN
during/IN
the/DT
initial/JJ
stages/NNS
of/IN
infection/NN
in/IN
which/WDT
Wp/NN
activity/NN
leads/VBZ
to/TO
the/DT
expression/NN
of/IN
EBNA/NN
2/CD
,/,
followed/VBN
by/IN
activation/NN
of/IN
Cp/NN
through/IN
the/DT
EBNA/NN
2-dependent/JJ
enhancer/NN
./.